"Enzyme Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds or factors that act on a specific enzyme to increase its activity.
| Descriptor ID |
D020536
|
| MeSH Number(s) |
D27.505.519.374
|
| Concept/Terms |
Enzyme Activators- Enzyme Activators
- Activators, Enzyme
- Activators of Enzymes
- Enzymes Activators
|
Below are MeSH descriptors whose meaning is more general than "Enzyme Activators".
Below are MeSH descriptors whose meaning is more specific than "Enzyme Activators".
This graph shows the total number of publications written about "Enzyme Activators" by people in this website by year, and whether "Enzyme Activators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 4 | 2 | 6 |
| 2019 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Enzyme Activators" by people in Profiles.
-
Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment. Future Microbiol. 2021 03; 16:205-209.
-
A Novel Angiotensin Converting Enzyme 2 (ACE2) Activating Peptide: A Reflection of 10 Years of Research on a Small Peptide Ile-Arg-Trp (IRW). J Agric Food Chem. 2020 Dec 09; 68(49):14402-14408.
-
An update on ACE2 amplification and its therapeutic potential. Acta Physiol (Oxf). 2021 01; 231(1):e13513.
-
Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial. Eur Respir J. 2019 10; 54(4).
-
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study. Lancet Respir Med. 2019 09; 7(9):780-790.
-
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study). Respir Res. 2018 Dec 19; 19(1):258.
-
Activation of AMPK alleviates cardiopulmonary bypass-induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder. Cardiovasc Ther. 2018 Dec; 36(6):e12482.
-
A dual regulatory circuit consisting of S-adenosylmethionine decarboxylase protein and its reaction product controls expression of the paralogous activator prozyme in Trypanosoma brucei. PLoS Pathog. 2018 10; 14(10):e1007404.
-
Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities. Food Chem Toxicol. 2018 Dec; 122:69-79.
-
Modulation of the Allosteric Communication between the Polo-Box Domain and the Catalytic Domain in Plk1 by Small Compounds. ACS Chem Biol. 2018 08 17; 13(8):1921-1931.